Bryan Johnson has spent roughly $2 million a year tracking nearly every measurable signal his body produces. For over a decade, one signal kept coming back wrong: persistently low iron, flagged repeatedly, never fully explained. His team ran the tests, checked the numbers, and kept moving. The disease doing it stayed hidden the entire time.
In July 2026, Johnson publicly disclosed that he had been diagnosed with autoimmune gastritis (AIG), a chronic condition in which the immune system destroys the stomach’s acid-producing cells. He posted on X that “my stomach is eating itself” and said he intended to solve it. The diagnosis arrived despite Johnson operating one of the most medically surveilled bodies on the planet, a fact that makes the case for taking AIG seriously even if you’ve never heard of it.
Johnson is best known for his “Project Blueprint” protocol, a self-funded experiment in life extension treatments that has attracted millions of followers and a Netflix documentary. He sold his company, Braintree, to PayPal for $800 million in 2013 and has since funneled a substantial portion of that wealth into his body. He spends approximately $2 million annually on therapies, supplements, and medical monitoring, working with a team of 30 medical professionals. That infrastructure didn’t prevent the diagnosis. His intensive testing program found it anyway, earlier than most patients ever would.
What Autoimmune Gastritis Actually Does
Autoimmune gastritis is a chronic, organ-specific autoimmune disease characterized by the immune-mediated destruction of gastric parietal cells, leading to impaired acid secretion, vitamin B12 deficiency, and an increased risk of gastric malignancies. Parietal cells matter because they do two critical jobs: they produce stomach acid, and they secrete a protein called intrinsic factor that the body needs to absorb vitamin B12 from food. When the immune system kills them off, both functions deteriorate.
Diagnosis is often delayed because of the absence of typical symptoms, and clinical guidelines are lacking, which results in inadequate treatment and poor cancer screening. The disease causes irreversible damage to the lining of the stomach and often develops silently and asymptomatically over the course of years. Many patients find out only after anemia or neurological symptoms appear, by which point significant damage has already occurred.
Standard blood test panels don’t screen for low B12 levels, though they do check for anemia, so that’s often the first clue that someone could have autoimmune gastritis. Johnson’s case was different: his intensive, custom blood testing caught persistently low ferritin (a protein that stores iron in cells) over more than a decade before any obvious symptoms surfaced. As Johnson wrote: “Low iron stores get normalized and rarely investigated at all when anemia hasn’t shown up yet. That blind spot is what hid mine for a decade.”
How Johnson’s Diagnosis Unfolded
After a decade of unexplained low ferritin despite normal hemoglobin, Johnson’s medical team performed a colonoscopy, a bi-directional endoscopy, and blood tests showing elevated anti-parietal cell antibodies. Stomach biopsies confirmed early-stage AIG.
Biopsy results showed “clear signs of early autoimmune gastritis: early atrophy confined to the acid-producing lining, with the rest of the stomach still spared,” Johnson wrote. The anti-parietal cell antibodies (APCA) in his blood came back at 103 Units/mL, roughly five times the upper limit of normal, which is set at 20 Units/mL. Early detection matters here because the stomach damage, once it progresses, cannot be reversed.
Johnson’s diagnosis wasn’t a surprise in isolation. He was diagnosed with autoimmune hypothyroidism at age 21 and has managed that condition with hormone replacement for over 27 years. Having one autoimmune condition significantly raises the risk of developing another. As Emeka Okeke, an immunologist and assistant professor of biology at Northeastern University, explained in a July 2026 interview with Northeastern Global News: “For most autoimmune diseases, the etiology is unknown, although we know that there are environmental and genetic factors that indicate who would have greater susceptibility.” The connection between Johnson’s thyroid disease and his gastritis isn’t coincidental – it fits a recognized pattern.
Why This Condition Is Easy to Miss
A 2026 review in Frontiers in Immunology estimated the global prevalence of autoimmune gastritis at around 3.85% of the population, but actual diagnoses run well below that. Gastroenterologists frequently miss the condition, partly because it mimics more common disorders and partly because standard screening panels don’t test for the specific antibodies that signal it.
The nutrient deficiencies it causes are well-documented. A 2024 study published in Digestive Diseases found that AIG patients have nearly three times the risk of iron deficiency compared to control patients, and over eleven times the risk of vitamin B12 deficiency. Those aren’t minor gaps. Severe B12 deficiency causes irreversible nerve damage. Chronic iron deficiency causes fatigue, cognitive fog, and anemia that compounds over years.
Autoimmune gastritis can also cause more obvious GI indicators, says Dr. Robert Huang, a gastroenterologist and clinical researcher at Stanford University whose research focuses specifically on gastric precancerous lesions including atrophic gastritis. Some patients experience bloating or feeling uncomfortably full after meals – symptoms they may mistake for heartburn or acid reflux. This is a condition called gastroparesis, in which the stomach empties food into the intestine more slowly than it should.
A 2023 study published in the Journal of Clinical Medicine found the incidence rate of gastric cancer in AIG patients to be 0.14% per person-year – low in absolute terms, but meaningfully elevated compared to the general population, and high enough to justify regular endoscopic surveillance. AIG also increases the risk of gastric malignancies more broadly, including a type of tumor called a gastric neuroendocrine tumor, which typically grows slowly and responds well to monitoring.
What Treatment Looks Like – and What Johnson Plans to Do About It
Autoimmune gastritis has no cure. Treatments focus on management through diet and vitamin supplementation, including oral iron and B12 supplements, or iron infusions and intramuscular B12 shots, which can be “more efficient,” according to Dr. Neil Parikh, Chief Innovation Officer and gastroenterologist at Connecticut GI, in restoring levels to a healthy baseline.
For patients whose stomach atrophy has progressed, oral B12 supplements often absorb too poorly to be effective, making injections a necessary long-term commitment. Johnson said he recently received a “1,000 mg Monoferric iron infusion” as part of his care plan. According to Vinmec International Hospital, patients with chronic autoimmune atrophic gastritis causing pernicious anemia will require lifelong supplementation.
Johnson has been clear that he doesn’t intend to stop at management. He has outlined a four-tier experimental approach to address his AIG, acknowledging there is “no approved cure” today. He is exploring experimental therapies, including immune cell reset and AI-designed antibodies. He wrote that “modern medicine has normalized too many conditions that erode our health, function, and comfort, shrinking the goal to monitoring and management while a cure is rarely even attempted. Most of these verdicts were handed down decades ago, in an era that predates nearly all of our current tech and science.”
The 2026 Frontiers in Immunology review noted that novel therapies aiming to reduce gastric atrophy and cancer risk are under development, but no approved curative treatment currently exists. The damage to parietal cells that has already occurred is permanent.
Johnson previously participated in plasma transfusions with his teenage son as part of anti-aging experiments. The FDA has stated there is “no proven clinical benefit” of plasma infusions from young donors for any aging-related use, and has not approved young plasma for any such conditions.
What This Means for You
Johnson’s diagnosis is unusual in its circumstances but not in its biology. Autoimmune gastritis is underdiagnosed partly because most people – and many doctors – aren’t looking for it. Even the most comprehensively monitored body on record had this condition hiding in plain sight for more than a decade, detectable only by a lab value most clinicians would have dismissed.
If you have another autoimmune condition, a family history of pernicious anemia, or have dealt with unexplained iron deficiency that doesn’t correct fully with supplementation, asking your doctor to test for anti-parietal cell antibodies is a reasonable step. Diagnosis of AIG relies on endoscopic findings combined with serological markers and histopathological confirmation – a blood test alone won’t catch it definitively, but elevated APCA levels are a clear signal to investigate further. Most people are able to live relatively normal lives with this condition, particularly when it’s caught early and nutrient levels are actively managed. The key is not waiting for symptoms to appear before asking the question.
Disclaimer: This information is not intended to be a substitute for professional medical advice, diagnosis, or treatment and is for information only. Always seek the advice of your physician or another qualified health provider with any questions about your medical condition and/or current medication. Do not disregard professional medical advice or delay seeking advice or treatment because of something you have read here.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
Read More: Biohacker Says 3 Months of Oxygen Therapy Took Decades Off His Biological Age